Sublocade provides continuous buprenorphine release for a month by which mechanism?

Study for the BIPC Substance Abuse and Disorders Exam. Challenge yourself with a variety of questions to enhance your knowledge and strengthen your preparation. Each question comes with hints and explanations to help you understand and retain crucial information.

Multiple Choice

Sublocade provides continuous buprenorphine release for a month by which mechanism?

Explanation:
The idea being tested is how long-acting injectable medications deliver drug. Sublocade is an extended‑release buprenorphine given as a monthly subcutaneous injection. After administration, it forms a subcutaneous depot and buprenorphine is released continuously over about a month, keeping steady therapeutic drug levels and supporting ongoing treatment. This is why the best choice is continuous release over a month. It’s not immediate-release, which would push most of the drug out quickly and require frequent dosing; it’s not a delayed-release with a gap before release, since release starts promptly and continues; and it’s not no release, since the drug is indeed released over the month.

The idea being tested is how long-acting injectable medications deliver drug. Sublocade is an extended‑release buprenorphine given as a monthly subcutaneous injection. After administration, it forms a subcutaneous depot and buprenorphine is released continuously over about a month, keeping steady therapeutic drug levels and supporting ongoing treatment. This is why the best choice is continuous release over a month. It’s not immediate-release, which would push most of the drug out quickly and require frequent dosing; it’s not a delayed-release with a gap before release, since release starts promptly and continues; and it’s not no release, since the drug is indeed released over the month.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy